Webinar Recording: PCI Ventures 2.0

Posted on February 26, 2021 — Jessica Jones Gupta

PCI Ventures, PCI’s dedicated startup team, recently updated and enhanced both of its flagship company formation programs. The goal of the PCIV program updates are to increase and further protect faculty equity interests when they choose to create a startup in partnership with Penn. Michael Poisel, Director of PCI Ventures, introduces and explains their updated…

PCI’s Ben Dibling featured on Technology Transfer IP podcast

Posted on February 24, 2021 — Jessica Jones Gupta

The Tech Transfer IP Forum podcast is devoted to providing in-depth analysis of intellectual property issues related to university and non-profit technology transfer. The forum will focus on life sciences, including biotechnology, chemical, medical device, pharmaceutical, and agricultural-related inventions, and will deliver updates on current domestic and international patent law relevant to technology transfer through…

Five years later: CAR T therapy shows long-lasting remissions in non-Hodgkin lymphomas

Posted on February 22, 2021 — Jessica Jones Gupta

Findings represent the longest follow-up data to date for a personalized cellular therapy approved by the FDA for the treatment of aggressive lymphomas. Read More on Penn Today

Rapid COVID-19 test developed at Penn could give on-the-spot results quickly

Posted on February 19, 2021 — Jessica Jones Gupta

A team of biologists and engineers led by César de la Fuente, Ph.D.at the University of Pennsylvania have built a rapid, recyclable and they believe reliable Covid-19 test. They say it could help wedding venues, restaurants and hotels detect infections and safely hold events. Read More at NBC 10 Philadelphia

The QED Proof-of-Concept Program is accepting applications starting March 1, 2021

Posted on February 18, 2021 — Jessica Jones Gupta

QED (from the Latin Quod Erat Demonstrandum – “that which is demonstrated”) invites academic researchers developing medical and life science technology with high commercial potential to apply for the annual competition. The Science Center’s QED program provides key resources to facilitate the commercial development of early-stage technologies, including customized business mentorship, preparation of a funding…

Pennovation’s ZeroEyes raised a $5M seed round as it adapts in the pandemic

Posted on — Jessica Jones Gupta

School shootings haven’t been happening since virtual learning started, but gun violence in America still rose last year. Here’s how ZeroEyes is responding. Read More in Technical.ly Philly

Penn Medicine cancer cell therapy pioneer Carl June named 2021 Dan David Prize Laureate

Posted on February 16, 2021 — Jessica Jones Gupta

International cancer cell therapy pioneer Carl June, the Richard W. Vague professor in Immunotherapy in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania and director of the Center for Cellular Immunotherapies at Penn’s Abramson Cancer Center, has been named a 2021 Dan David Prize Laureate. Read More in Penn Today

The world’s first general purpose computer turns 75

Posted on February 12, 2021 — Jessica Jones Gupta

The Electronic Numerical Integrator and Computer (ENIAC), built at the Moore School of Electrical Engineering, sparked the ‘birth of the computer age’ thanks to a team of women programmers. Read More on Penn Today

College student’s simple invention helps nurses work and patients rest

Posted on February 11, 2021 — Jessica Jones Gupta

The device, a wearable night light that can minimize disturbances for sleeping patients, is the brainchild of a University of Pennsylvania senior and a neonatal I.C.U. nurse. Read More in the NY Times.

Tmunity expands Penn pact, picking up another CAR-T program, rights to manufacturing tech

Posted on February 10, 2021 — Jessica Jones Gupta

Tmunity Therapeutics was born out of an extensive collaboration with the University of Pennsylvania that netted it the technology, know-how and programs it needed to go after better cell therapies for cancer. Now, the biotech is bolstering that pact, picking up a new CAR-T program and the rights to certain technologies. Under the original partnership,…